University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Papers in Communication Studies

Communication Studies, Department of

2017

The Role of Health Care Provider and Partner
Decisional Support in Patients’ Cancer Treatment
Decision-Making Satisfaction
Angela L. Palmer-Wackerly
University of Nebraska-Lincoln, apalmer-wackerly2@unl.edu

Janice L. Krieger
University of Florida, janicekrieger@jou.ufl.edu

Nancy D. Rhodes
Michigan State University, rhodesn3@msu.edu

Follow this and additional works at: http://digitalcommons.unl.edu/commstudiespapers
Part of the Critical and Cultural Studies Commons, Gender, Race, Sexuality, and Ethnicity in
Communication Commons, and the Other Communication Commons
Palmer-Wackerly, Angela L.; Krieger, Janice L.; and Rhodes, Nancy D., "The Role of Health Care Provider and Partner Decisional
Support in Patients’ Cancer Treatment Decision-Making Satisfaction" (2017). Papers in Communication Studies. 185.
http://digitalcommons.unl.edu/commstudiespapers/185

This Article is brought to you for free and open access by the Communication Studies, Department of at DigitalCommons@University of Nebraska Lincoln. It has been accepted for inclusion in Papers in Communication Studies by an authorized administrator of DigitalCommons@University of
Nebraska - Lincoln.

Palmer-Wackerly

et al. in

Journal

of

Health Communication 22 (2017)

1

Published in Journal of Health Communication, 22: 10–19, 2017.
doi 10.1080/10810730.2016.1245804
Copyright © 2017 Taylor & Francis Group, LLC. Used by permission.

The Role of Health Care Provider and
Partner Decisional Support in Patients’
Cancer Treatment Decision-Making
Satisfaction
Angela L. Palmer-Wackerly,1 Janice L. Krieger,2
and Nancy D. Rhodes 3
1 Department of Communication Studies, University of Nebraska–Lincoln, Lincoln,
Nebraska, USA
2 Department of Advertising, College of Journalism and Communications, University of
Florida, Gainesville, Florida, USA
3 Department of Advertising and Public Relations, College of Communication Arts and
Sciences, Michigan State University, Lansing, Michigan, USA
Corresponding author — Angela L. Palmer-Wackerly, Department of Communication Studies,
University of Nebraska–Lincoln, 432 Oldfather Hall, Lincoln, NE 68588, USA;
email apalmer-wackerly2@unl.edu
ORCID:

Janice L. Krieger http://orcid.org/0000-0001-9950-9170
Nancy D. Rhodes http://orcid.org/0000-0002-2539-9682

Abstract
Cancer patients rely on multiple sources of support when making treatment decisions; however, most research studies examine the influence of
health care provider support while the influence of family member support is understudied. The current study fills this gap by examining the influence of health care providers and partners on decision-making satisfaction. In a cross-sectional study via an online Qualtrics panel, we surveyed
cancer patients who reported that they had a spouse or romantic partner
when making cancer treatment decisions (n = 479). Decisional support was
measured using 5-point, single-item scales for emotional support, informational support, informational-advice support, and appraisal support. Decision-making satisfaction was measured using Holmes-Rovner and colleagues’ (1996) Satisfaction With Decision Scale. We conducted a mediated
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regression analysis to examine treatment decision-making satisfaction for
all participants and a moderated mediation analysis to examine treatment
satisfaction among those patients offered a clinical trial. Results indicated
that partner support significantly and partially mediated the relationship
between health care provider support and patients’ decision-making satisfaction but that results did not vary by enrollment in a clinical trial. This
study shows how and why decisional support from partners affects communication between health care providers and cancer patients.

In the United States, cancer is the second leading cause of death
(American Cancer Society, 2015), with 40% of adults estimated to
develop cancer in their lifetime (National Cancer Institute, 2014).
Cancer is considered both a life crisis and an illness that affects patients’ family and friends (National Cancer Institute, 2014). To cope
with cancer and receive assistance with treatment decision making
(DM), patients turn to health care providers (HCPs) and loved ones
as sources of support when considering information about their diagnosis and treatment options (Arora, Finney Rutten, Gustafson, Moser,
& Hawkins, 2007; Siminoff, Zyzanski, Rose, & Zhang, 2008). The DM
process is stressful for patients and their families as they consider
types of available treatment, weigh treatment benefits and risks, cope
with uncertainty, and manage the additional burden on themselves
and their families (e.g., treatment side effects, transportation costs, financial concerns; Siminoff, 2013).
Despite the team-centered nature of cancer care communication,
however, medical DM research has historically focused on communication between the patient and HCP (Street, 2013), with less DM
research focused on the patient and family (Krieger et al., 2015). Furthermore, as scholars have noted, the role of communication from both
family members and HCPs during this DM process is understudied
(Albrecht, Penner, Cline, Eggly, & Ruckdeschel, 2009; Arora, Street,
Epstein, & Butow, 2009; Krieger, 2014; Quaschning, Körner, & Wirtz,
2013). In addition, treatment decisions that involve scientific or medical uncertainty (i.e., unknown effectiveness of treatment) or risk (i.e.,
unknown side effects), such as clinical trials (CTs), can be especially
problematic for patients’ DM satisfaction (Politi, Clark, Ombao, Dizon, & Elwyn, 2011). Thus, the current article examines patients’ DM
satisfaction in relation to (a) support from HCPs and partners (i.e.,
significant others) and (b) patients’ specific CT decision.
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Decisional Support
One way to examine others’ influence on patients’ treatment DM is
to consider enacted social support, or how supportive messages are
communicated (Goldsmith, 2004). This definition of support is different from other definitions of social support that focus on the quantity, frequency, structure, and availability of perceived social support,
which, unlike enacted support, do not consider the quality and appropriateness of support (Goldsmith, 2004). Enacted social support
primarily includes four dimensions: emotional support (i.e., expressions of caring, concern, and empathy), informational support (i.e.,
information and advice), tangible support (i.e., offers of goods and
services), and appraisal support (i.e., providing new perspectives on
problems; Goldsmith & Albrecht, 2011).
Social support given and received during a DM context has been
defined as decisional support (Krieger, 2014). Decisional support varies according to individual preferences of patients and families and
ranges from patient autonomy (the patient assumes/controls all decisional rights and responsibilities) to patient interdependence (the
patient gives some/all decisional rights and responsibilities to family members; for a review, see Krieger, 2014). When aligned between
patients and family members, decisional support can result in positive health outcomes (e.g., less distress for the patient); however, it
can also increase patients’ distress if this support leads to conflict
between decisional partners about treatment preferences (Siminoff,
Rose, Zhang, & Zyzanski, 2006).
HCP and Partner Decisional Support
In recent decades, HCPs have increasingly focused on the treatment
goals of patients through patient-centered communication (PCC),
which includes fostering healing relationships, exchanging information, responding to emotions, making decisions, and managing uncertainty (Arora et al., 2009). A core tenet of PCC is the belief that HCPs
should support the needs of the whole person, which includes considering the influence of family members in the DM process (Epstein
& Street, 2007). Family members provide decisional support to patients by assisting patients in seeking, organizing, and processing information for health decisions, including finding an HCP, receiving
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advice about cancer treatment, and describing symptoms to providers (Krieger et al., 2015; Siminoff et al., 2006). However, family members have also been shown to pressure patients to choose treatments
that are less burdensome to the family and adhere to patients’ family’s values instead of HCP recommendations (Siminoff, 2013). In cancer DM, spouses are often the primary source of support (Miller &
Caughlin, 2013), and extant research associates spousal communication with psychosocial outcomes, such as distress and adjustment
to diagnosis (Harris et al., 2009). Thus, scholars have called for more
research determining the role of family support in (a) patient–provider communication and (b) patients’ psychosocial outcomes (e.g.,
Albrecht et al., 2009; Ballard-Reisch & Letner, 2003; Harris et al., 2009;
Street, 2013). Given that patients may differ in their perceived decisional support from HCPs and partners (Siminoff, 2013), we examine how partner support is related to the relationship between HCP
support and patient DM satisfaction.
One possibility is that partner support may partially mediate the
relationship between HCP support and patient DM satisfaction for
three reasons. First, some patients, even if they have supportive family members, prefer to rely primarily on HCP support to make their
treatment decision (Krieger, 2014). Thus, we expect a direct relationship to exist between HCP support and patient DM satisfaction. Second, in a clinical interaction, HCPs typically first initiate conversations about treatment with patients and supportive others who may
be attending the appointment (Street, 2013). Third, although patient
conversations with supportive others often continue beyond the clinical interaction before a decision is made by patients, HCPs have the
ability to improve family support by encouraging patients to talk to
family members to ask for the emotional, informational, and tangible
help they need (Street, 2013; Street, Makoul, Arora, & Epstein, 2009).
Building on this past research, we conceptualize HCP support as occurring before partner support in patients’ DM process (see Figure 1).
Clinical Trial Decision-Making
CTs are viewed as a critical resource for improving cancer care
through treatment advances (Baquet, Commiskey, Mullins, & Mishra,
2006); however, fewer than 5% of cancer patients enroll in CTs
(Umutyan et al., 2008). Research has primarily focused on identifying
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Fig. 1. Theoretical model of mediation of social support and decision-making satisfaction (PROCESS Model 4). Indirect effect = (a × b). Total effect (c) = c′ + (a × b).
HCP = health care provider.

enrollment barriers, yet scholars agree that more research should focus on patients’ quality of DM and family and HCP support for those
decisions (Stepan et al., 2011; Yang et al., 2010). One study found that
patients felt more confident about their CT decision when they had
more information and alliance with HCPs and family members (Albrecht et al., 2008). As a result, patients who enroll in a CT might have
higher DM satisfaction when they view members of their decisional
support team (i.e., family and HCPs) as participating in their treatment decisions (i.e., giving support).
Based on the literature discussed previously, we present the following hypotheses and research questions. Where we know the direction of relationships based on extant research, we hypothesize the
predicted relationships between variables. Where relationships are
not established in the literature, we present research questions to explore the connections between variables. Thus, we present the hypotheses and research questions in the order that the tested relationships appear in the models (see Figures 1 and 2):

Fig. 2. Theoretical model of moderated mediation of CT enrollment on social support and decision-making satisfaction (PROCESS Model 14). Indirect effect = (a ×
b). Total effect (c) = c′ + (a × b). HCP = health care provider; CT = clinical trial.
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Hypothesis 1: Patients’ perceived decisional support from HCPs
will relate positively to patients’ cancer treatment DM
satisfaction.
Research Question 1: How will patients’ perceived decisional support from partners relate to patients’ DM satisfaction?
Research Question 2: How will patients’ perceived decisional support from HCPs relate to patients’ perceived decisional
support from partners?
Hypothesis 2: Patients’ perceived partner support will partially mediate the effects of patients’ perceived HCP support on
patient DM satisfaction.
In addition, we examine whether the relationship between decisional support and patient DM satisfaction varies with whether patients enroll in a CT (see Figure 2). Thus, we present the final research
question:
Research Question 3: Does the decision to enroll in a CT moderate
the effects of patients’ perceived partner and HCP support on patients’ DM satisfaction?

Method
Sample and Recruitment
Participants (N = 667) included patients ages 18 years or older who
had received a cancer diagnosis within the past 2 years. Ages ranged
from 18 to 89 (M = 48.9, SD = 17.0). A subsample of participants (n
= 481) responded “yes” to the question “At the time you were making decisions about your cancer treatment, did you have a significant
other (spouse, partner, etc.)?” However, two participants in this subset were removed from final analyses because of missing data on HCP
support and income measures. Thus, analyses were subsequently
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restricted to a subsample of 479 participants. The majority of these
participants were female and White, with ages ranging from 20 to
89 years old (M = 48.1, SD = 16.5). Participant characteristics are reported in Table 1.
Table 1. Participant statistics
		
Characteristic
Total sample
(N = 667)
Age
18–24
38 (5.7)
25–34
144 (21.6)
35–44
114 (17.1)
45–54
96 (14.4)
55–64
122 (18.3)
65–74
108 (16.2)
75+
45 (6.7)
Sex
Female
416 (62.4)
Male
251 (37.6)
Race
White
568 (85.2)
African American
50 (7.5)
Asian/Asian American/Pacific Islander 35 (5.2)
Native American/Eskimo
4 (0.6)
Other
10 (1.5)
Education
HS incomplete
12 (1.8)
HS graduate
93 (13.9)
Technical/trade/vocational after HS
55 (8.2)
Some college
192 (28.8)
College graduate (4-year degree)
233 (34.9)
Postgraduate
82 (12.3)
U.S. annual income
Less than $10,000
18 (2.7)
$10,000 to less than $20,000
47 (7.0)
$20,000 to less than $30,000
73 (10.9)
$30,000 to less than $40,000
87 (13.0)
$40,000 to less than $50,000
64 (9.6)
$50,000 to less than $75,000
160 (24.0)
$75,000 to less than $100,000
113 (16.9)
$100,000 to less than $150,000
80 (12.0)
$150,000+
24 (3.6)

Partner and
HCP support
(n = 479)

CT offer
(n = 104)

15 (8.1)
32 (17.3)
23 (12.4)
29 (15.7)
36 (19.5)
36 (19.5)
14 (7.6)

2 (1.9)
31 (29.8)
31 (29.8)
18 (17.3)
12 (11.5)
9 (8.7)
1 (1.0)

293 (61.2)
186 (38.8)

71 (68.3)
33 (31.7)

408 (85.2)
34 (7.1)
26 (5.4)
3 (0.6)
8 (1.7)

75 (72.1)
12 (11.5)
14 (13.5)
0 (0)
3 (2.9)

6 (1.3)
67 (14.0)
40 (8.4)
141 (29.4)
171 (35.7)
54 (11.3)

0 (0)
10 (9.6)
11 (10.6)
30 (28.8)
38 (36.5)
15 (14.4)

9 (1.9)
15 (3.1)
44 (9.2)
59 (12.3)
46 (9.6)
123 (25.7)
92 (19.2)
70 (14.6)
21 (4.4)

2 (1.9)
4 (3.8)
4 (3.8)
17 (16.3)
7 (6.7)
27 (26.0)
22 (21.2)
16 (15.4)
5 (4.8)

Data are n (%). HCP = health care provider; CT = clinical trial; HS = high school.
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As for CT offers, approximately 20% (n = 133) of the original sample of patients (N = 667) responded “yes” to the question “Were you
offered an opportunity to participate in a cancer research study as
part of your treatment?” Likewise, within the subsample of 479 participants with partner support, only 104 (21.7%) of these participants
were offered a CT (see Table 2). Among these 104 participants, ages
ranged from 23 to 78 (M = 42.9, SD = 12.9). The most common types
of cancer were breast and prostate, with more than a third of participants having received a cancer diagnosis in the 6 months prior to participating in our study (see Table 2 for participants’ clinical cancer information, such as diagnosis and CT enrollment).
Table 2. Participant clinical information
			
Characteristic
Total sample
		
(N = 667)
CT offer
Yes
133 (19.9)
No
534 (80.1)
CT enrollment
Yes
78 (11.7)
No
589 (88.3)
Time since most recent cancer diagnosis
Less than 3 months ago
92 (13.8)
3–6 months ago
134 (20.1)
7–12 months ago
195 (29.2)
13–24 months ago
246 (36.9)
Most recent cancer type
Breast
195 (29.2)
Prostate
86 (12.9)
Colon or rectal
39 (5.8)
Lung
70 (10.5)
Melanoma
88 (13.2)
Bladder
19 (2.8)
Other
198 (29.7)
Chances cancer is/will be cured
90% or better
270 (40.5)
About 75%
152 (22.8)
About 50%–50%
143 (21.4)
About 25%
29 (4.3)
10% or less
24 (3.6)
I don’t know
49 (7.3)

Partner and
HCP support
(n = 479)

CT offer
(n = 104)

104 (21.7)
375 (78.3)

104 (100.0)
0 (0.0)

66 (13.8)
413 (86.2)

66 (63.5)
38 (36.5)

69 (14.4)
93 (19.4)
141 (29.4)
176 (36.7)

17 (16.3)
21 (20.2)
40 (38.5)
26 (25.0)

152 (31.7)
67 (14.0)
28 (5.8)
43 (9.0)
62 (12.9)
14 (2.9)
137 (28.6)

48 (46.2)
16 (15.4)
10 (9.6)
11 (10.6)
13 (12.5)
2 (1.9)
18 (17.3)

191 (39.9)
116 (24.2)
97 (20.3)
24 (5.0)
17 (3.5)
34 (7.1)

20 (19.2)
34 (32.7)
28 (26.9)
10 (9.6)
7 (6.7)
5 (4.8)

Data are n (%). HCP = health care provider; CT = clinical trial.
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For 1 week in May 2014, participants were recruited from an online Qualtrics panel (i.e., a pool of U.S. adults who have volunteered
to participate in online survey research via Qualtrics). Participants
were randomly selected to participate in this institutional review
board–approved study through an e-mail invitation with an embedded secure, individualized link to the survey. Survey questions focused on the attitudes and experiences of cancer survivors. Responses
were anonymous and confidential, and no personal identifiers were
linked to participants.
Participants who chose to opt in to the study read an introductory page that described the study and its purpose and requested
their consent to participate. Once they gave their consent, participants completed the survey. After survey completion, participants
received a debriefing statement, which provided contact information for the principal investigators if they had any questions about
the survey or their participation. All study participants received a
cash value reward that was credited to their member account on the
site and could be redeemed for a gift card (e.g., Amazon.com, Payoneer prepaid debit, restaurants. com). The reward amount was based
on recruiting incentives, which were adjusted for survey length and
target audience.
Questionnaire
Decisional Support Measures
Decisional support measures were adapted from established definitions of enacted support (Goldsmith, 2004) and based on the social support dimensions reported by patients to be the most important types of decisional support in their cancer CT treatment DM in a
previous study (Krieger, Palmer-Wackerly, Dailey, & Krok, 2013). Because this was the first time this scale was being used, we also wanted
to test the feasibility of using a shortened decisional support scale.
Decisional support was measured using a 5-point Likert scale asking whether patients had received any treatment DM help by others
(a) “showing care and concern for me” (i.e., emotional support), (b)
“giving me valuable information about my treatment options” (i.e.,
informational support), (c) “giving me advice about which treatment
option would be better for me” (i.e., informational advice support),
and (d) “giving me a different point of view” (i.e., appraisal support).
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Responses ranged from strongly disagree (1) to strongly agree (5), and
the scale was repeated across two separate support sources: HCP (i.e.,
oncologist) and partner (i.e., significant other). Scale items resulted
in reliability for partner support (α = .84) and HCP support (α = .85).
A principal component analysis (PCA) was conducted on the decisional support items. We wanted to examine whether the scale reported that participants recognized support types as separate and distinct subconcepts or whether participants viewed support types as
belonging to only one concept. For each support source, a PCA was
conducted for decisional support survey items. All coefficients in the
correlation matrix were 0.3 and above. Kaiser–Meyer–Olkin values
were 0.781 (HCP) and 0.775 (partner), and Bartlett’s test of sphericity was significant for both sources, thus making factor analysis appropriate for both of these source scales (Pallant, 2013). Analysis of
both scales resulted in one component with eigenvalues exceeding
1: 2.848 (HCP) and 2.726 (partner), which explained 71% (HCP) and
68% (partner) of the variance. Thus, we combined scale items for each
source separately into two variables (HCP and partner) by using the
mean score across each case for each support source.
CT Participation Measure
CT participation was measured by asking patients who were offered a CT the following: “Did you agree to participate in the cancer
research study you were offered?” Responses were “yes” and “no.”
DM Satisfaction Measures
DM satisfaction was measured using a 5-point Likert scale created from four questions from the Satisfaction With Decision Scale
(Holmes-Rovner et al., 1996): (a) “I am satisfied that I was adequately
informed about the issues important to my decision,” (b) “The treatment decision I made was the best decision possible for me personally,” (c) “I am satisfied with the outcome of my decision,” and (d) “I
am satisfied that my decision was consistent with my personal values.” Possible responses ranged from strongly disagree (1) to strongly
agree (5). Scale reliability was high (α = .88). Using the guidelines
above for PCA (Pallant, 2013), results showed that the test was appropriate and that one component was present with an eigenvalue
exceeding 1: 2.968, which explained 74% of the variance. Thus, scale
items were combined into one variable by using the mean score of
scale items for each case.
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Some researchers claim that quality DM is more important than satisfaction with DM in determining patients’ well-being. These reasons
include the need to accurately assess patients’ knowledge about options, patients’ understanding of risk involved with treatments, and/
or how well the DM process matches patients’ value system (Politi et
al., 2011). In consideration of these reasons, we chose Holmes-Rovner
and colleagues’ (1996) satisfaction with DM scale because it privileges
patients’ perspective in asking patients to evaluate how informed they
believed they were, how good the decision was for them, how satisfied they were with the outcome, and how consistent the decision was
with their personal values. Likewise, patients do not always engage in
systematic processing when making treatment decisions and instead
engage in naturalistic (i.e., intuition-based) and/or heuristic processing (Epstein, 2013). Patients desire different levels of information depending on where they are located in the illness trajectory (Marcus
et al., 2013). In the cancer context specifically, patients have initially
reported feeling overwhelmed and experiencing difficulty processing information after their diagnosis. However, it is precisely at this
moment that treatment options are often discussed because of medical concerns about cancer progression, and this is why it is often suggested that patients bring loved ones to their appointments (Krieger,
2014). These appointments can also be overwhelming for caregivers,
and factors such as motivation, knowledge, and communication skills
have been shown to influence how well people understand and communicate with HCPs about health information (Epstein & Street, 2007).
Thus, satisfaction with DM, although not the only measure for quality of DM, is an important indicator of decisional quality because it
indicates that patients have met their goals and considered their values (i.e., PCC), which have been linked to less decisional conflict and
increased well-being (Glass et al., 2012).
Data Analysis
All analyses of survey information about cancer treatment attitudes
were conducted in SPSS (Version 22; IBM, New York, NY). Frequencies and distributions of demographic and behavioral variables (see
Table 1) and the reliability of scale items were assessed. Three key
variables (i.e., HCP support, partner support, and DM satisfaction)
were negatively skewed; thus, they were transformed by reflecting and inversing the scores to allow for more normally distributed
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responses in order to meet the statistical assumptions of the techniques below (Tabachnick & Fidell, 2014, p. 87).
Using the PROCESS macro in SPSS, we tested the hypothesized
partial mediation model (see Figure 1; Model 4 in PROCESS) and
moderated mediation model (see Figure 2; Model 14 in PROCESS;
Hayes, 2013; Preacher & Hayes, 2004; Preacher, Rucker, & Hayes,
2007).Within the PROCESS macro of SPSS, Model 4 tests a simple mediation model, whereas Model 14 tests a moderated mediation model
with the moderation occurring between the mediating and dependent
variables (see Figures 1 and 2; Hayes, 2013; Preacher & Hayes, 2004).
Through these analyses, the relationships between all variables were
estimated. In PROCESS Model 4, the mediation model’s test of significance for the indirect effect was conducted to estimate path a from
the predictor variable (i.e., HCP support) to the mediating variable
(i.e., partner support), path b from the mediating variable to the outcome variable (i.e., DM satisfaction), and path c′ from the predictor
variable to the outcome variable (see Figure 1). The indirect effect was
quantified as the product of the direct effect of HCP support on partner support and the direct effect of HCP support on DM satisfaction.
The total effect of HCP support on DM satisfaction (path c) was estimated by adding the direct effect (path c′) and indirect effect (paths
a × b; Hayes, 2013; Preacher & Hayes, 2004). Bootstrapping (i.e., indirect effects estimated from repeated sampling) was conducted in order to generate a valid 95% confidence interval for statistical inference
(Hayes, 2013; Preacher & Hayes, 2004). All analyses controlled for sex,
age, education, ethnicity, and income (see Table 1 for frequencies).
A moderated mediation analysis was conducted using participants who had been offered the opportunity to participate in a CT
and reported a romantic partner (n = 104). Using the PROCESS macro
in SPSS, we used Model 14 (see Figure 2) to conduct a test of significance for the indirect and conditional effects to estimate path a from
the predictor variable (i.e., HCP support) to the mediating variable
(i.e., partner support), path b from the mediating variable to the outcome variable (i.e., DM satisfaction), path c′ from the predictor variable to the outcome variable, and the conditional effect of a CT decision (yes/no) on DM satisfaction. Indirect and direct effects were
estimated using the same procedures detailed in the previous paragraph. Bootstrapping was conducted with 5,000 samples to test significance and obtain a valid 95% confidence interval (Hayes, 2013;
Preacher & Hayes, 2004; Preacher et al., 2007).
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Results
HCP Support and DM Satisfaction (Hypothesis 1)
Descriptive statistics and Pearson’s correlation test results are reported in Table 3. Hypothesis 1 predicted that HCP support would
be positively associated with patients’ DM satisfaction. After we controlled for demographic variables, results from a mediated regression
model show a significant direct effect of HCP support on the likelihood of DM satisfaction (path c′ in Hayes, 2013; Preacher & Hayes,
2004; b = 0.420, p < .001; see Table 4). Thus, independent of partner
support, a direct effect existed between HCP support and the likelihood of reporting patient DM satisfaction. Thus, Hypothesis 1 was
supported.
Partner Support and DM Satisfaction (Research Question 1)
Research Question 1 explored the association between partner support and patients’ DM satisfaction. After we controlled for demographic variables, the mediation model found that the direct effect of
partner support on DM satisfaction (path b in Hayes, 2013) was positive and significant (b = 0.090, p < .001; see Table 4).

Table 3. Descriptive statistics and Pearson’s correlations between variables
						Pearson’s r
Variable

M

SD

Range

1

2

1. Partner support

3.9

0.9

1.0–5.0

—

2. HCP support

4.1

0.8

1.0–5.0 		

3
.481**

—

3. Clinical trial decision 						
4. DM satisfaction

4.4

Age

48.2

0.7

4
.156†

.213**

.064

.429**

—

1.0–5.0 				

16.6 20.0–89.0

−.32** −.12**

Sex (1 = male, 2 = female) 				

.11*

Education 				

.02

−.06

.01

Ethnicity				

.06

.03

−.01

Income				

.04

.01

.03

HCP = health care provider; DM = decision making.
† p < .10 ; * p < .05 ; ** p < .001

.11*

−.01
−.18*

.08
—
.19**
.09†
−.05
−.08†
.03
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Table 4. Regression results for mediation
Panel A: Variable

Coefficient

t

p

CI

DM satisfaction regressed on HCP support (c)

0.463

11.125

<.001

[0.382, 0.545]

Partner support regressed on HCP support (a)

0.483

11.434

<.001

[0.400, 0.566]

DM satisfaction regressed on partner support

0.090

1.990

<.05

[0.001, 0.179]

0.420

8.950

<.001

[0.328, 0.512]

controlling for HCP support (b)
DM satisfaction regressed on HCP support
controlling for partner support (c′)
CI = confidence interval; DM = decision making; HCP = health care provider

HCP Support and Partner Support (Research Question 2)
Research Question 2 explored the association between HCP support
and partner support. After we controlled for demographic variables, results from a mediated regression test found that the direct effect of HCP
support on partner support (path a in Hayes, 2013; Preacher & Hayes,
2004) was positive and significant (b = 0.483, p < .001; see Table 4).
Mediation of Partner Support on HCP Support and Patient DM
Satisfaction (Hypothesis 2)
Hypothesis 2 predicted that partner support would indirectly mediate
the relationship between HCP support and patient DM satisfaction
(see Figure 1). Results from the model indicated a partial mediation
with both an indirect and direct effect of HCP support on patients’
DM satisfaction (see Table 4). The indirect effect of HCP support on
DM satisfaction through partner support was the product of paths a
and b: 0.483 × 0.090 = 0.044. This means that a patient who reported
1 unit higher on the HCP support scale was estimated to report 0.044
units higher in DM satisfaction through the effect of partner support.
The indirect effect was statistically different from zero, as evidenced
by the 95% confidence interval for the indirect effect created by the
5,000 bootstrap samples [0.001, 0.089]. We estimated the total effect
of HCP support on DM satisfaction (path c in Hayes, 2013; Preacher
& Hayes, 2004) by adding the direct effect and indirect effect: 0.420 +
0.044 = 0.463 (p < .001). Thus, Hypothesis 2 was supported through a
partial and significant mediation effect of partner support on the relationship between HCP support and patient DM satisfaction.
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CT Enrollment Interaction Effect (Research Question 3)
Research Question 3 examined whether the relationship between decisional support from HCPs and partners and DM satisfaction varied with CT enrollment. A correlation matrix indicated the strength
and significance of support source on CT decision (see Table 3). Both
HCP and partner support were positively correlated with CT decision, though the relationships were not significant. A moderated mediation regression analysis (see Figure 2) showed that HCP support
was positively and significantly associated with patients’ DM satisfaction (b = 0.370, p < .001) and that no other relationships were significant. Specifically, the interaction between partner support and CT
decision was positive though not significantly different from zero (b =
0.038, p = .78; see Table 5). Thus, the results did not support the moderated effect of CT enrollment on the mediation of partner support on
the relationship between HCP support and patient DM satisfaction.

Discussion
Scholars have called for more research that identifies factors, such as
family social support, that affect the relationship between HCP communication and treatment outcomes (Epstein, 2013; Krieger, 2014;
Street, 2013). Our results demonstrate that partner support partially
mediates the relationship between HCP support and patients’ DM
satisfaction within the cancer treatment context. In addition, our
results showed that both HCP and partner support were significant, independent, and positive predictors of patient DM satisfaction, even after we controlled for demographic characteristics (e.g.,

Table 5. Regression results for moderated mediation
Panel A: Variable

Coefficient

t

p

CI

HCP support

0.370

4.409

<.001

[0.204, 0.537]

Partner support

0.075

0.662

.51

[−0.148, 0.297]

−0.020 −0.220

.83

[−0.198, 0.158]

.78

[−0.236, 0.313]

Decision-making satisfaction regressed on

CT enrollment
Interaction (Partner Support × CT)

0.038

0.277

CI = confidence interval; HCP = health care provider; CT = clinical trial
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gender, race). Our results confirm that HCP support is a stronger
predictor of DM satisfaction than partner support but that higher
HCP support also encourages more partner support, which influences patients’ decision satisfaction. Results, however, did not vary
with CT enrollment.
HCP and Partner Support
We found that most patients reported that HCP support was highly
influential in their DM satisfaction. This finding for HCP support
is encouraging given the focus on patient-centered care in medical DM and patient perceptions of HCP credibility and knowledge
(e.g., Street, 2013). This finding shows that for cancer treatment DM,
patients value the support their HCP gives them, and, when effective, this support influences patient satisfaction. These findings also
showed that CT enrollment did not affect the relationship between
decisional support and patient decisional satisfaction. This result is
promising for patient well-being in that it may suggest that patients
are feeling supported in their treatment decision from both partners
and HCPs, no matter their CT decision.
Partner support was shown to be positively associated with patients’ medical DM; however, variability existed among patients in
the extent to which this support influenced their decision. In addition, the direct effect on DM satisfaction was small, which supports
previous cancer DM research in that patients do not always seek
and/or value support from their family and that, conversely, families do not always give the support that a patient desires from them
(e.g., Krieger, 2014). Patients also viewed types of support (e.g., emotional, informational, advice, and appraisal) as similarly influential
to their treatment decision for both support sources. Although some
scholars (e.g., Arora et al., 2007) have suggested using separate dimensions of social support, the PCA indicated that decisional support types blended together for the patients even though support
sources (i.e., HCP vs. partner) had different associations with decisional satisfaction. A variety of mechanisms could explain this finding: (a) Patients may have wanted to receive both information and
emotional care from their HCP; (b) by communicating information,
HCPs were also communicating their concern for patients; and/or
(c) single-item measures are not distinct enough to identify unique
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differences among types of decisional support (Arora et al., 2007).
However, for the purposes of this study, we wanted to explore the
influence of support source more than support type as well as explore
the utility of a shortened decisional support scale; thus, the current
scale was appropriate for our analysis.
These results also suggest that in addition to PCC with HCPs, patients could also benefit from PCC with family members— focusing
on patient goals and values for treatment. Just as shared DM models between HCPs and patients have moved to a mutually influential
style of communicating—one that respects patients’ goals and level
of involvement (Arora et al., 2009)—so too could shared DM models
with family members incorporate respect for patients’ goals and their
level of involvement. Of course, PCC may be more emotionally difficult for caregivers (as opposed to HCPs), who are personally and relationally invested and perceive cancer to be affecting the entire family
(Krieger et al., 2015; Hasson-Ohayon, Goldzweig, Braun, & Galinsky, 2010). Thus, future family cancer communication interventions
could explore how to educate both patients and caregivers on the importance of PCC in shared illness identity and its personal and relational implications, such as identifying and respecting patients’ desire for the family’s level of involvement in DM in order to increase
patient well-being and decrease decisional conflict for families.

Strengths and Limitations
As other researchers have noted, many relational influences (e.g.,
friends, siblings, children) influence the clinical encounter both before and after these visits (Harris et al., 2009). Strengths of our study
include a large sample of cancer patients with partners (n = 479), a
large subsample of patients who were offered a cancer CT and had
partners (n = 104), and the combined consideration of two relational
influences (i.e., HCPs and partners) on patients’ DM satisfaction. Although a minority of adult cancer patients (fewer than 5%) enroll in
a CT (Umutyan et al., 2008), approximately 12% of our total sample
enrolled in a CT, and 14% of the patients who had partners enrolled
in a CT. Although our sample participated in CTs at a higher rate
than the general population, CT participants are often difficult to recruit given their small percentages of enrollment. Thus, the current
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analyses remain informative in examining the relationship between
CT decisional support and decisional satisfaction, and the higher percentage of CT enrollees is a strength of the study.
One limitation of our study is that we did not ask about length of
time since treatment or current cancer diagnosis; thus, we are unsure
how many patients still had cancer versus how many were in remission. Because CT participants are difficult to recruit, we asked participants to enroll in our study if they had received a cancer diagnosis within 2 years (instead of a shorter time frame). It is possible that
patients in remission may have biased recall around DM indicating
a more positive experience; however, we believe this limitation to be
of little concern because participants’ clinical information showed
that 35% of the 479 cancer participants and 48% of the 104 CT participants in our sample reported that they thought their chances of having their cancer cured were 50% or less.
An additional limitation is that our findings only represent cancer patients who have significant others. The current study specifically looked at partner support because partners and HCPs have been
shown to be the most influential sources of support for cancer patients (e.g., Miller & Caughlin, 2013). However, the findings cannot
be generalized to cancer patients who rely on other caregivers, such
as a close friend, sibling, or child because they either are not married, have lost a partner, or find more support in other relationships.
Future studies should instead consider the combined influence of a
primary support network source (as opposed to a significant other)
to account for these differences and increase generalizability among
cancer patients. This may especially be true for young adult cancer
patients who may rely more heavily on their parents rather than a
significant other.
Finally, we tested our models assuming a temporal relationship
between HCP support, partner support, and patients’ DM satisfaction. This assumption was made based on three extant findings in the
literature: (a) Sometimes patients prefer to confer only with HCPs in
medical DM, (b) HCPs typically initiate treatment conversations in
a cancer context, and (c) HCPs encourage family/friend support in
cancer DM (Krieger, 2014; Street, 2013; Street et al., 2009). Though
a causal relationship cannot be inferred from the cross-sectional
data provided in this study, the results suggest an explanation for a
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process (MacKinnon, 2008) through which HCPs influence patients’
DM satisfaction (i.e., HCP support leads to partner support, which
leads to DM satisfaction). Future studies should consider temporal
study designs to appropriately test causal linkages. Finally, patients
surveyed through a Qualtrics Web survey present a selection bias in
any sample because they likely (a) have an interest in research, (b)
are motivated to participate to receive monetary remuneration, and/
or (c) have more advanced technological skills than the average cancer patient.

Conclusions and Implications
The goal of this study was to examine the dual influences of both
HCPs and partners in patients’ medical DM satisfaction. This study
furthers knowledge of social support by showing how and why support from partners affects communication between HCPs and patients
within the cancer clinical DM context. Likewise, support from both
HCPs and family members did not vary with CT enrollment, which
shows that patients were satisfied with decisional support and their
treatment decision no matter if they accepted or declined a CT. With
continued theoretical development, interventions can be developed
and tested to ensure that patients’ decisional needs for support are
met from all medical and social network members.
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